LeadIQ logo
Learn more at LeadIQ.com
DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company logo

DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company Employee Directory

Biotechnology ResearchCalifornia, United States51-200 Employees

DICE Therapeutics, Inc. is a biotechnology research company focused on developing oral medicines for chronic autoimmune and inflammatory diseases, grounded in validated immunology targets. By combining innovative chemistry with well-validated biology, it aims to make treatments more accessible and unlock the potential of oral therapies. The organization operates as a wholly owned subsidiary of Eli Lilly and Company and is based in South San Francisco, California, with a mid-sized team.

Its leadership comprises scientists and senior executives with track records of advancing programs from discovery through regulatory milestones toward commercialization. The firm is building a pipeline of novel oral candidates across immunology and related therapeutic areas, supported by a platform that underpins small molecule discovery and development.

Find DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company employees' phone numbers or email addresses

DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company Global Highlights

Location
Employees

North America
32

Minus sign iconPlus sign icon
  • United States Of America
    31
  • Canada
    1

Africa
3

Minus sign iconPlus sign icon
  • Egypt
    2
  • Nigeria
    1

Europe
3

Minus sign iconPlus sign icon
  • France
    1
  • Netherlands
    1
  • Germany
    1

Asia
2

Minus sign iconPlus sign icon
  • India
    2

DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company's Leadership

  • President at DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
    J. R.
    President
    Mobile Phone
  • Controller at DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
    L. E.
    Controller
    Mobile Phone
  • Controller at DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
    L. E.
    Controller
    Mobile Phone
  • Senior Document Specialist at DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
    D. W.
    Senior Document Specialist
    Mobile Phone
  • Officer at DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
    S. R.
    Officer
    Mobile Phone

DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company Employee Metrics

100%
50%
0%
2026
2025
  • Administrative
  • Biotechnology
  • Business
  • Branding
  • Human Resources
  • Other
  • Analytics

Contact profiles from DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company

Name
Title
Contact
Location
Last Update
  • President at DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
    J. R.
    President
    Mobile Phone
    Oct 16, 2024
  • Controller at DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
    L. E.
    Controller
    Mobile Phone
    May 02, 2024
  • Controller at DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
    L. E.
    Controller
    Mobile Phone
    Oct 23, 2024
  • Senior Document Specialist at DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
    D. W.
    Senior Document Specialist
    Mobile Phone
    Oct 17, 2024
  • Officer at DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
    S. R.
    Officer
    Mobile Phone
    Feb 27, 2024

Frequently Asked Questions

What is DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company known for?

Minus sign iconPlus sign iconDICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company was founded in 2013 and operates in the Biotechnology Research industry. You can contact DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company's main corporate office by phone at
+1-650-566-****
. Explore DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company's company overview page for more information.

What is DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company's most common email format?

Minus sign iconPlus sign iconDICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company employees' email format typically follows the pattern of FLast@dicemolecules.com. Trying to find reliable and up-to-date employee contact data? Find more DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company email formats with LeadIQ.

How many employees does DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company have currently?

Minus sign iconPlus sign iconDICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company has approximately 67 employees as of July 2026. These team members are located across 4 continents, including North America, Africa and Europe.

Who are DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company's key employees and leadership?

Minus sign iconPlus sign icon

As of July 2026, DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company's key employees include:

  • President: J. R.
  • Controller: L. E.
  • Controller: L. E.
  • Senior Document Specialist: D. W.
  • Officer: S. R.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

  • B2B data verified in real-time
  • Sync data to your CRM, & add it to an outreach sequence in one click
  • Integrations with your tech stack for optimal efficiency
  • A patented AI cold email generator
  • Account & contact-level job change tracking

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.